Glenmark Pharmaceuticals Performance
- Today's Low
- ₹2,229
- Today's High
- ₹2,288
- 52 Week Low
- ₹1,793
- 52 Week High
- ₹2,474
- Open Price₹2,288
- Previous Close₹2,287
- Volume496,330
- 50 DMA₹2,232.80
- 100 DMA₹2,195.60
- 200 DMA₹2,096.00
Glenmark Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 4.63%
- Over 3 Month -0.62%
- Over 6 Month + 11.74%
- Over 1 Year + 0.4%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 46.3
- PEG Ratio
- 1.5
- Market Cap Cr
- 63,086
- P/B Ratio
- 6
- Average True Range
- 56.6
- EPS
- 48.3
- Dividend Yield
- 0.2
- MACD Signal
- 17.5
- RSI
- 49.28
- MFI
- 76.43
Latest Stock News Updates
Glenmark Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30, 2026
- BSE India
- 2 days 18 hours ago
Glenmark Pharmaceuticals share price can rise to 2,500
- Business Line
- 1 week 4 days ago
Glenmark Pharmaceuticals Inc., USA launches Olanzapine for Injection, 10 mg/vial, Single - Dose Vial
- BSE India
- 1 week 5 days ago
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹2,245.20
- 50 Day
- ₹2,232.80
- 100 Day
- ₹2,195.60
- 200 Day
- ₹2,096.00
Resistance and Support
- R3 2,331.50
- R2 2,309.70
- R1 2,272.60
- S1 2,213.70
- S2 2,191.90
- S3 2,154.80
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredient to regulated and semi-regulated markets. View More- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Popular Stocks
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,235 As on 18 July, 2026 | 10:11
The Market Cap of Glenmark Pharmaceuticals is ₹63086 Cr As on 18 July, 2026 | 10:11
The P/E ratio of Glenmark Pharmaceuticals is 46.3 As on 18 July, 2026 | 10:11
The PB ratio of Glenmark Pharmaceuticals is 6 As on 18 July, 2026 | 10:11
The 52 week High & Low of Glenmark Pharmaceuticals is ₹2474/₹1792.6 respectively As on 18 July, 2026 | 10:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.